✦ LIBER ✦

Evidence that a Hybrid Molecule of Norfloxacin and Biphenylacetic Acid is a Potent Antagonist at the GABAA Receptor

✍ Scribed by T IMANISHI; K AKAHANE; N AKAIKE

Book ID: 117187898
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 697 KB
Volume: 35
Category: Article
ISSN: 0028-3908
DOI: 10.1016/s0028-3908(96)00058-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The bile steroid chenodeoxycholate is a

The bile steroid chenodeoxycholate is a potent antagonist at NMDA and GABAA receptors

✍ S.R. Schubring; W. Fleischer; J.S. Lin; H.L. Haas; O.A. Sergeeva 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 603 KB

Evidence that the plant cannabinoid cann

Evidence that the plant cannabinoid cannabigerol is a highly potent α2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist

✍ MG Cascio; LA Gauson; LA Stevenson; RA Ross; RG Pertwee 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 451 KB

Selectivity of d[Cha4]AVP and SSR149415

Selectivity of d[Cha4]AVP and SSR149415 at human vasopressin and oxytocin receptors: evidence that SSR149415 is a mixed vasopressin V1b/oxytocin receptor antagonist

✍ Cristiana Griffante; Andrew Green; Ornella Curcuruto; Carl P Haslam; Bryony A Di 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 216 KB

Fipamezole (JP-1730) is a potent α2 adre

Fipamezole (JP-1730) is a potent α2 adrenergic receptor antagonist that reduces levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease

✍ Juha-Matti Savola; Michael Hill; Mia Engstrom; Hannele Merivuori; Siegfried Wurs 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

Previous studies in the MPTP-lesioned primate model of Parkinson's disease have demonstrated that alpha(2) adrenergic receptor antagonists such as idazoxan, rauwolscine, and yohimbine can alleviate L-dopa-induced dyskinesia and, in the case of idazoxan, enhance the duration of anti-parkinsonian acti

7-Chlorokynurenic Acid is a Selective An

7-Chlorokynurenic Acid is a Selective Antagonist at the Glycine Modulatory Site of the N-methyl-D-aspartate Receptor Complex

✍ J. A. Kemp, A. C. Foster, P. D. Lesson, T. Priestley, R. Tridgett, L. L. Iversen 📂 Article 📅 1988 🏛 National Academy of Sciences 🌐 English ⚖ 913 KB

SCH-C (SCH 351125), an orally bioavailab

SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo

✍ Strizki, J. M.; Xu, S.; Wagner, N. E.; Wojcik, L.; Liu, J.; Hou, Y.; Endres, M.; 📂 Article 📅 2001 🏛 National Academy of Sciences 🌐 English ⚖ 149 KB